MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
13.18
-0.03 (-0.23%)
At close: Dec 31, 2025, 4:00 PM EST
13.10
-0.08 (-0.61%)
After-hours: Dec 31, 2025, 7:30 PM EST
MLTX Market Cap
MLTX has a market cap or net worth of $940.7 million as of December 31, 2025. Its market cap has decreased by -72.26% in one year.
Market Cap
940.70M
Enterprise Value
635.95M
1-Year Change
-72.26%
Ranking
Category
Stock Price
$13.18
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $940.70M, an increase of 26,044.61%. That is a compound annual growth rate of 320.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 942.84M | -72.39% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
| Feb 14, 2022 | 3.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |